Emma Hodcroft

Last updated

Emma B. Hodcroft
Emma Hodcroft (2020).jpg
Emma Hodcroft
Born1986
EducationTexas Christian University (TCU), University of Edinburgh
Parents
Website emmahodcroft.com

Emma Hodcroft (born 1986) is a British-American [1] molecular epidemiologist at the Institute for Social and Preventive Medicine at the University of Bern. [2] [3] [4] Her research focuses on the phylogenetics of viruses and other pathogens, mapping the spread and evolution of different genetic variants. Hodcroft is a developer on the Nextstrain project, [5] an open science project that tracks the transmission chains of SARS-CoV-2 and other pathogens. [6] In 2020, she originated CoVariants.org, a project tracking SARS-CoV-2 variants. [7]

Contents

Nextstrain's work gained global prominence during the COVID-19 pandemic and have been cited widely in scientific and media coverage. [8] [9] [10] [11] As a scientist tracking the spread of the virus across the globe, Hodcroft has co-authored papers on topics including how the early pandemic spread from country to country, the potential for seasonality, and the prevalence and spread of variants of concern. [12] [13] [14]

Early life and education

Hodcroft was born to an American mother, Ellen Louise Boyer, and British father, Ken Hodcroft. [15] After her parents divorced, she and her two younger siblings split their year between Texas and Scotland. [8] [15]

Hodcroft studied for her undergraduate degree in biology at Texas Christian University (TCU). She worked with Professor John Horner, studying the carnivorous Sarracenia alata pitcher plants, studying the genetic variation among geographically distinct plant populations. This work showed that clonal reproduction, thought to be common among the species, was in fact quite low. [4]

Later, Hodcroft studied for a master's degree at the University of Edinburgh, which she received with distinction. Her thesis looked for evidence of adaptive selection in Drosophila, by comparing the rate of changes across tissue types, periods of time, and between immune-related and non-immune related functions. [4]

Hodcroft received her Ph.D. at Edinburgh with Prof. Andrew Leigh Brown. Her thesis studied the phylogenetic factors influencing viral load in HIV. [16] Her three-minute summary of her thesis won the school- and country-level award in the 3 Minute Thesis Competition and placed third in the global competition. [17] [18]

Research and career

Hodcroft's research has focused on computational methods of tracking genetic changes in pathogens and their impact on disease and epidemiological dynamics. She is currently a post-doc working on Nextstrain with Richard Neher. [17]

HIV

Hodcroft's doctoral work studied the phylogenetic factors influencing viral load in HIV, analyzing the genetic sequences of 8,500 HIV samples in the United Kingdom. She found that variations in HIV B strains were responsible for only a small fraction in the variations of viral load in patients, while HIV C strains showed a greater degree of viral influence over viral load. [19] [16] She completed her first postdoctoral position with the PANGEA_HIV initiative, continuing in the laboratory of Prof. Leigh Brown. Hodcroft developed a stochastic, agent-based model for the simulation of HIV epidemics in Africa developed south of the Sahara. [20]

Nextstrain

Hodcroft is a developer on the Nextstrain project, [5] an open science project that tracks the transmission chains of SARS-CoV-2 and other pathogens. Her work included expanding Nextstrain to efficiently analyze bacterial pathogens, which have significantly larger genomes than viruses.

Hodcroft's research then focused on Enterovirus D68, the virus implicated in outbreaks of a polio-like disorder called acute flaccid myelitis. The work culminated in publishing a phylogenetic analysis of the evolution, geographic spread, and demographic distribution of the pathogen. [21] [22]

SARS-CoV-2

During the COVID-19 pandemic, scientific and public interest in viral dynamics soared. Hodcroft made significant contributions maintaining ongoing analysis of the outbreak in Nextstrain, starting a new site to track SARS-CoV-2 variants, and explaining the outbreak dynamics to the public. [7] [8] [9] [10] [11] As a scientist tracking the spread of the virus across the globe, Hodcroft has published and been quoted on multiple topics, including how the early pandemic spread from country to country, the potential for seasonality, and the prevalence and spread of variants of concern. [12] [13] [14]

Early in the pandemic, Hodcroft became intrigued by how a lone traveler from Singapore could have trigger a rash of cases in the United Kingdom. She posted an infographic on Twitter tracking the spread from the Singapore traveler, to fellow guests at a ski chalet in Switzerland, to the outbreak in the UK. A colleague suggested she publish the work, she posted the article on 26 February and it was published the next day in Swiss Medical Weekly . [23]

Over the following months, phylogenetic analysis and open science platforms like Nextstrain played a key role in efforts to understand the epidemic. [24] This work helped to understand transmission patterns, track key mutations, and estimate the speed of epidemic spread. [14] In October 2020, Hodcroft and the Nextstrain team published an analysis that showed that the strain driving an emerging wave in the United Kingdom had first emerged in Spain — indicating that holiday travel to and from Spain was a likely source of the outbreak. [25] Hodcroft has published on the history of competing SARS-CoV-2 strains to better understand the emergence of variants of concern. [26] [27] Hodcroft has written about the round-the-clock nature of gathering, analyzing, error-checking, and annotating the flood of genomic data from around the world. [8] [14]

In March 2021, Hodcroft was the lead author of a commentary in Nature about how the scientific community could track virus variants faster. [28] The article recommended ways to "fix the bioinformatics bottleneck," including improving the rules and incentives for data sharing, rethinking incentives for midcareer academics, and accommodating the challenges of analyzing vast volumes of data, often from labs that have not collected and reports data in such volumes.[ clarification needed ] It pointed out that much of the genetic tracking of SARS-CoV-2 had not been performed by public health authorities, but rather by mid-career academics who set aside their own research to help the pandemic efforts. The article called on the scientific community to rethink the incentives for these researchers, so their efforts would not set back their careers. Similarly, the article called on the community to find ways to standardize data sharing, and to ensure that researchers can share data prior to publication without having their own findings pre-empted.

In 2020, she originated CoVariants.org, a project tracking SARS-CoV-2 variants. [7]

Hodcroft has also emerged as a science communicator, both on social media and in the press. She has been quoted in articles about the transmission of the virus, [29] debunking the conspiracy theory that the virus was artificially created, [30] and describing the role of holiday travel in spreading the virus, [31] and the impact of emerging variants of concern. [32]

Papers

As of March 2021, Hodcroft is named as a co-author in 23 papers: [33]

Presentations

Hodcroft has presented her work on HIV at Conference on Retroviruses and Opportunistic Infections (CROI) 2012 in Seattle, WA, and CROI 2013 in Atlanta, GA, and at many conferences, including the 45th Population Genetics Group Conference in Nottingham, England, and the 19th, 20th, and 21st HIV Dynamics and Evolution Conferences in Asheville, NC; Utrecht, the Netherlands; and Tucson, AZ. [17]

Awards

Hodcroft's entry in the 2014 Three Minute Thesis competition, "Do some strains of HIV make people sick more quickly than others?" won first prize and the 'people's choice' award at the University of Edinburgh finals of the '3 Minute Thesis competition'. A video of the presentation placed 3rd in the world-wide Universitas 21 competition in 2014. [17] [18]

The Nextstrain tool, co-developed by Hodcroft, received a Webby Special Achievement Award in May 2020. [34]

In March 2021, The New York Times listed Hodcroft as a scientist in a new generation "changing the landscape of leadership" for women in science. [35]

Related Research Articles

<span class="mw-page-title-main">GISAID</span> Global initiative for sharing virus data

GISAID, the Global Initiative on Sharing All Influenza Data, previously the Global Initiative on Sharing Avian Influenza Data, is a global science initiative established in 2008 to provide access to genomic data of influenza viruses. The database was expanded to include the coronavirus responsible for the COVID-19 pandemic, as well as other pathogens. The database has been described as "the world's largest repository of COVID-19 sequences". GISAID facilitates genomic epidemiology and real-time surveillance to monitor the emergence of new COVID-19 viral strains across the planet.

<span class="mw-page-title-main">W. Ian Lipkin</span> Professor, microbiologist, epidemiologist

Walter Ian Lipkin is the John Snow Professor of Epidemiology at the Mailman School of Public Health at Columbia University and a professor of Neurology and Pathology at the College of Physicians and Surgeons at Columbia University. He is also director of the Center for Infection and Immunity, an academic laboratory for microbe hunting in acute and chronic diseases. Lipkin is internationally recognized for his work with West Nile virus, SARS and COVID-19.

<span class="mw-page-title-main">Emerging Pathogens Institute</span>

The Emerging Pathogens Institute (EPI) is an interdisciplinary research institution associated with the University of Florida. The institute focuses on fusing key disciplines to develop outreach, education, and research capabilities designed to preserve the region's health and economy, as well as to prevent or contain new and re-emerging diseases. Researchers within the institute work in more than 30 different countries around the world, with over 250 affiliated faculty members stemming from 11 University of Florida colleges, centers, and institutes. The 90,000-square-foot building includes laboratories and collaborative space for bioinformatics and mathematical modeling.

<span class="mw-page-title-main">Vaccine Research Center</span>

The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.

<span class="mw-page-title-main">Human coronavirus OC43</span> Species of virus

Human coronavirus OC43 (HCoV-OC43) is a member of the species Betacoronavirus 1, which infects humans and cattle. The infecting coronavirus is an enveloped, positive-sense, single-stranded RNA virus that enters its host cell by binding to the N-acetyl-9-O-acetylneuraminic acid receptor. OC43 is one of seven coronaviruses known to infect humans. It is one of the viruses responsible for the common cold and may have been responsible for the 1889–1890 pandemic. It has, like other coronaviruses from genus Betacoronavirus, subgenus Embecovirus, an additional shorter spike protein called hemagglutinin-esterase (HE).

<span class="mw-page-title-main">Superspreading event</span> Event in which 3 or more people attend and an infectious disease is spread much more than usual

A superspreading event (SSEV) is an event in which an infectious disease is spread much more than usual, while an unusually contagious organism infected with a disease is known as a superspreader. In the context of a human-borne illness, a superspreader is an individual who is more likely to infect others, compared with a typical infected person. Such superspreaders are of particular concern in epidemiology.

Spillover infection, also known as pathogen spillover and spillover event, occurs when a reservoir population with a high pathogen prevalence comes into contact with a novel host population. The pathogen is transmitted from the reservoir population and may or may not be transmitted within the host population. Due to climate change and land use expansion, the risk of viral spillover is predicted to significantly increase.

<span class="mw-page-title-main">Tanja Stadler</span> German mathematician and professor of computational evolution

Tanja Stadler is a mathematician and professor of computational evolution at the Swiss Federal Institute of Technology. She’s the current president of the Swiss Scientific Advisory Panel COVID-19 and Vize-Chair of the Department of Biosystems Science and Engineering at ETH Zürich.

<span class="mw-page-title-main">SARS-CoV-2</span> Virus that causes COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. The virus previously had the provisional name 2019 novel coronavirus (2019-nCoV), and has also been called human coronavirus 2019. First identified in the city of Wuhan, Hubei, China, the World Health Organization designated the outbreak a public health emergency of international concern from January 30, 2020, to May 5, 2023. SARS‑CoV‑2 is a positive-sense single-stranded RNA virus that is contagious in humans.

Pandemic prevention is the organization and management of preventive measures against pandemics. Those include measures to reduce causes of new infectious diseases and measures to prevent outbreaks and epidemics from becoming pandemics.

Susan R. Weiss is an American microbiologist who is a Professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania. She holds vice chair positions for the Department of Microbiology and for Faculty Development. Her research considers the biology of coronaviruses, including SARS, MERS and SARS-CoV-2. As of March 2020, Weiss serves as Co-Director of the University of Pennsylvania/Penn Medicine Center for Research on Coronavirus and Other Emerging Pathogens.

Christophe Fraser is a professor of Infectious Disease Epidemiology in the Big Data Institute, part of the Nuffield Department of Medicine at the University of Oxford.

Viral interference, also known as superinfection resistance, is the inhibition of viral reproduction caused by previous exposure of cells to another virus. The exact mechanism for viral interference is unknown. Factors that have been implicated are the generation of interferons by infected cells, and the occupation or down-modulation of cellular receptors.

<span class="mw-page-title-main">COVID-19 Genomics UK Consortium</span> British genomics research consortium

The COVID-19 Genomics UK (COG-UK) consortium was a group of academic institutions and public health agencies in the United Kingdom created in April 2020 to collect, sequence and analyse genomes of SARS-CoV-2 at scale, as part of COVID-19 pandemic response.

<span class="mw-page-title-main">Variants of SARS-CoV-2</span> Notable variants of SARS-CoV-2

Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are viruses that, while similar to the original, have genetic changes that are of enough significance to lead virologists to label them separately. SARS-CoV-2 is the virus that causes coronavirus disease 2019 (COVID-19). Some have been stated, to be of particular importance due to their potential for increased transmissibility, increased virulence, or reduced effectiveness of vaccines against them. These variants contribute to the continuation of the COVID-19 pandemic.

Nextstrain is a collaboration between researchers in Seattle, United States and Basel, Switzerland which provides a collection of open-source tools for visualising the genetics behind the spread of viral outbreaks.

<span class="mw-page-title-main">Phylogenetic Assignment of Named Global Outbreak Lineages</span> SARS-CoV-2 lineage nomenclature

The Phylogenetic Assignment of Named Global Outbreak Lineages (PANGOLIN) is a software tool developed by Dr. Áine O'Toole and members of the Andrew Rambaut laboratory, with an associated web application developed by the Centre for Genomic Pathogen Surveillance in South Cambridgeshire. Its purpose is to implement a dynamic nomenclature to classify genetic lineages for SARS-CoV-2, the virus that causes COVID-19. A user with a full genome sequence of a sample of SARS-CoV-2 can use the tool to submit that sequence, which is then compared with other genome sequences, and assigned the most likely lineage. Single or multiple runs are possible, and the tool can return further information regarding the known history of the assigned lineage. Additionally, it interfaces with Microreact, to show a time sequence of the location of reports of sequenced samples of the same lineage. This latter feature draws on publicly available genomes obtained from the COVID-19 Genomics UK Consortium and from those submitted to GISAID. It is named after the pangolin.

<span class="mw-page-title-main">SARS-CoV-2 variant of concern</span> Highly transmissible and virulent strains of SARS-CoV-2

The term variant of concern (VOC) for SARS-CoV-2, which causes COVID-19, is a category used for variants of the virus where mutations in their spike protein receptor binding domain (RBD) substantially increase binding affinity in RBD-hACE2 complex, while also being linked to rapid spread in human populations.

DRASTIC is a loose collection of internet activists assembled to investigate the origins of COVID-19, in particular the lab leak theory. Composed of about 30 core members, and primarily organized through the social media website Twitter, DRASTIC was formed in February 2020, at the start of the COVID-19 pandemic. DRASTIC members called for a "full and unrestricted investigation" into the origins of COVID-19, conducted independently of the World Health Organization; most scientists thought that COVID-19 likely had a natural origin, and some considered that a potential lab leak was worth investigating.

William Paul Duprex is a British scientist and advocate for vaccines and global health. He serves as Director of the University of Pittsburgh's Center for Vaccine Research and Regional Biocontainment Laboratory. Duprex holds the Jonas Salk Chair in Vaccine Research. He is also a professor of microbiology and molecular genetics at the University of Pittsburgh School of Medicine and serves as Editor-in-Chief of the Journal of General Virology, which is published by the Microbiology Society, and a senior editor of mSphere, published by the American Society for Microbiology. Duprex is an expert in measles and mumps viruses and studies viral spillover from animals to humans, including the SARS-CoV-2 virus that caused the COVID-19 pandemic. Duprex is a Fellow of the American Academy of Microbiology.

References

  1. ↑ Lüthi T, Hirstein A. "Emma Hodcroft: "I am never not thinking about the pandemic"". NZZ am Sonntag. Retrieved 9 March 2021.
  2. ↑ Callaway E (September 2020). "The coronavirus is mutating - does it matter?". Nature. 585 (7824): 174–177. Bibcode:2020Natur.585..174C. doi:10.1038/d41586-020-02544-6. PMID   32901123. S2CID   221573069.
  3. ↑ "Hodcroft Emma, PhD". Institute of Social and Preventive Medicine (ISPM). 17 November 2020. Retrieved 9 March 2021.
  4. 1 2 3 "Emma Hodcroft - PhD". emmahodcroft.com. Retrieved 9 March 2021. Home: Welcome to emmahodcroft.com
  5. 1 2 "Nextstrain". nextstrain.org. Retrieved 9 March 2021.
  6. ↑ Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, et al. (December 2018). "Nextstrain: real-time tracking of pathogen evolution". Bioinformatics. 34 (23): 4121–4123. doi:10.1093/bioinformatics/bty407. PMC   6247931 . PMID   29790939.
  7. 1 2 3 "CoVariants". covariants.org. Retrieved 28 March 2021.
  8. 1 2 3 4 Saraga D (15 May 2020). "Emma Hodcroft: The 'virus hunter'". SWI swissinfo.ch. Retrieved 9 March 2021.
  9. 1 2 Toy S (20 February 2021). "Covid-19 Vaccination Delays Could Bring More Virus Variants, Impede Efforts to End Pandemic". Wall Street Journal. ISSN   0099-9660 . Retrieved 9 March 2021.
  10. 1 2 Cookson C (29 October 2020). "Scientists warn of new coronavirus variant spreading across Europe | Free to read". www.ft.com. Retrieved 9 March 2021.
  11. 1 2 Grubaugh ND, Hodcroft EB, Fauver JR, Phelan AL, Cevik M (March 2021). "Public health actions to control new SARS-CoV-2 variants". Cell. 184 (5): 1127–1132. doi:10.1016/j.cell.2021.01.044. ISSN   0092-8674. PMC   7846239 . PMID   33581746.
  12. 1 2 Neher RA, Dyrdak R, Druelle V, Hodcroft EB, Albert J (March 2020). "Potential impact of seasonal forcing on a SARS-CoV-2 pandemic" (PDF). Swiss Medical Weekly. 150: w20224. doi: 10.4414/smw.2020.20224 . PMID   32176808. S2CID   212739046.
  13. 1 2 Fauver JR, Petrone ME, Hodcroft EB, Shioda K, Ehrlich HY, Watts AG, et al. (March 2020). "Coast-to-coast spread of SARS-CoV-2 in the United States revealed by genomic epidemiology". medRxiv   10.1101/2020.03.25.20043828 .
  14. 1 2 3 4 Hodcroft EB, De Maio N, Lanfear R, MacCannell DR, Minh BQ, Schmidt HA, et al. (March 2021). "Want to track pandemic variants faster? Fix the bioinformatics bottleneck" (PDF). Nature. 591 (7848): 30–33. Bibcode:2021Natur.591...30H. doi: 10.1038/d41586-021-00525-x . PMID   33649511.
  15. 1 2 Hall J (24 August 2018). "Football club owner's daughter rises from despair to chutney queen". ChronicleLive. Retrieved 9 March 2021.
  16. 1 2 University of Edinburgh (30 June 2014). "Emma Hodcroft's Three Minute Thesis". YouTube . Retrieved 27 March 2021.
  17. 1 2 3 4 "About Emma Hodcroft". emmahodcroft.com. Retrieved 13 February 2021. About Me: About Emma Hodcroft
  18. 1 2 "History of the (3 Minute Thesis) competition". www.ed.ac.uk. Retrieved 13 February 2021.
  19. ↑ Hodcroft EB (2015). "Estimating the Heritability of Virulence in HIV". Edinburgh Research Archive. Retrieved 14 December 2023.
  20. ↑ Yebra G, Hodcroft EB, Ragonnet-Cronin ML, Pillay D, Brown AJ (December 2016). "Using nearly full-genome HIV sequence data improves phylogeny reconstruction in a simulated epidemic". Scientific Reports. 6 (1): 39489. Bibcode:2016NatSR...639489Y. doi:10.1038/srep39489. PMC   5180198 . PMID   28008945.
  21. ↑ Hodcroft EB, Dyrdak R, Andrés C, Egli A, Reist J, de Artola DG, et al. (18 January 2020). "Evolution, geographic spreading, and demographic distribution of Enterovirus D68" (PDF). bioRxiv: 2020.01.10.901553. doi:10.1101/2020.01.10.901553. S2CID   211142598.
  22. ↑ "Enterovirus D68". nextstrain.org. Retrieved 28 March 2021.
  23. ↑ Yeager, Ashley (6 March 2020). "Coronavirus's Genetics Hint at its Cryptic Spread in Communities". The Scientist Magazine®. Retrieved 28 March 2021.
  24. ↑ Zastrow M (May 2020). "Open science takes on the coronavirus pandemic". Nature. 581 (7806): 109–110. Bibcode:2020Natur.581..109Z. doi:10.1038/d41586-020-01246-3. PMID   32332909. S2CID   216129647.
  25. ↑ Hodcroft EB, Zuber M, Nadeau S, Crawford KH, Bloom JD, Veesler D, et al. (November 2020). "Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020". medRxiv   10.1101/2020.10.25.20219063 .
  26. ↑ Lauring AS, Hodcroft EB (February 2021). "Genetic Variants of SARS-CoV-2-What Do They Mean?". JAMA. 325 (6): 529–531. doi: 10.1001/jama.2020.27124 . PMID   33404586. S2CID   230783233.
  27. ↑ Grubaugh ND, Hodcroft EB, Fauver JR, Phelan AL, Cevik M (March 2021). "Public health actions to control new SARS-CoV-2 variants". Cell. 184 (5): 1127–1132. doi:10.1016/j.cell.2021.01.044. ISSN   0092-8674. PMC   7846239 . PMID   33581746.
  28. ↑ Hodcroft EB, De Maio N, Lanfear R, MacCannell DR, Minh BQ, Schmidt HA, et al. (March 2021). "Want to track pandemic variants faster? Fix the bioinformatics bottleneck" (PDF). Nature. 591 (7848): 30–33. Bibcode:2021Natur.591...30H. doi: 10.1038/d41586-021-00525-x . PMID   33649511.
  29. ↑ "A Covid-19 Detective Tracks Disease Trail With Genetic Clues". Bloomberg.com. 24 March 2020. Retrieved 28 March 2021.
  30. ↑ "No, the coronavirus wasn't made in a lab. A genetic analysis shows it's from nature". Science News. 26 March 2020. Retrieved 28 March 2021.
  31. ↑ "Researchers Say 90% Of Recent Coronavirus Sequences In U.K. Came From Spain". NPR.org. Retrieved 28 March 2021.
  32. ↑ Mandavilli A (25 February 2021). "The Coronavirus Is Threatening a Comeback. Here's How to Stop It". The New York Times. ISSN   0362-4331 . Retrieved 28 March 2021.
  33. ↑ "ORCID: Emma Hodcroft". orcid.org. Retrieved 10 March 2021.
  34. ↑ "Webby Special Achievement". winners.webbyawards.com. Retrieved 29 December 2020.
  35. ↑ "10 Women Changing the Landscape of Leadership". The New York Times. 5 March 2021. ISSN   0362-4331 . Retrieved 9 March 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.